Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - December 2014


Cold Chain Distribution

02 Dec 2014 - 03 Dec 2014 - London, UK



Bookmark and Share


Join the 9th annual Cold Chain Distribution event and be part of a major networking opportunity providing intimate interaction with your peers, where you will hear case studies, presentations and round table discussions on the key issues surrounding the global healthcare cold chain distribution process and logistic requirements for various temperature sensitive healthcare products.

In addition, Cold Chain Distribution-2014 includes this fantastic networking opportunity: Dinner at Gordon Ramsay's Maze Restaurant sponsored by World Courier on the evening of December 2nd.

Event Highlights:

  • Hear from MHRA GDP Inspector, Cheryl Blake, will be providing attendees with regulatory guidance in her presentation entitled: GDP Compliance - A UK Regulatory Perspective, on Day 1 of the conference
  • Benchmark and reflect on the implementation of the GDP directive with case studies from IATA, AbbVie and the Dutch Health Care Inspectorate
  • Enhance your understanding of the challenges of transport qualification for temperature sensitive pharmaceutical products with a round table discussion led by Tony Wright, Managing Director, Exelsius Cold Chain Management and an opening address from Alan Dorling, Global Head – Pharmaceutical & Life Sciences, IAG Cargo
  • Strengthen your supply chains through management and efficiency insights from Merck Serono and Genzyme

Speaker Faculty-2014 includes:

  • Gianpiero Lorusso, Supply Chain Manager, Merck Serono 
  • Didier Basseras, VP Global Head of Clinical Supplies & Supply Chain, Sanofi Aventis R&D 
  • Thomas Grubb, Manager, Cold Chain Strategy, American Airlines 
  • Mark Riches, Logistics Manager, Public Health England 
  • Tim Wood, Technical Service Manager, GSK 
  • Michelle Goodyear, QA Manager, AbbVie 
  • Tony Wright, Managing Director, Exelsius Cold Chain Management
  • Chris Wallace, Distribution Director, Genzyme 
  • David Spillett, Business Development Manager, Biopharm Services, World Courier 
  • Alan Dorling, Global Head - Pharmaceuticals & Life Sciences, IAG Cargo

Plus, many more at this year's event.

For more information, contact Fateja Begum on +44 (0) 207 827 6184 or fbegum@smi-online.co.uk



Further information
Scientific News
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!